Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for BioRestorative Therapies (BRTX) over the last 14 years, with Q3 2025 value amounting to $7.8 million.

  • BioRestorative Therapies' Cash & Current Investments fell 4059.56% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 4059.56%. This contributed to the annual value of $20.4 million for FY2024, which is 8407.2% up from last year.
  • As of Q3 2025, BioRestorative Therapies' Cash & Current Investments stood at $7.8 million, which was down 4059.56% from $11.7 million recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Cash & Current Investments registered a high of $30.5 million during Q1 2024, and its lowest value of $1.1 million during Q3 2021.
  • Over the past 5 years, BioRestorative Therapies' median Cash & Current Investments value was $14.7 million (recorded in 2022), while the average stood at $14.9 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 5222027.2% in 2021, then crashed by 7014.35% in 2025.
  • Over the past 5 years, BioRestorative Therapies' Cash & Current Investments (Quarter) stood at $1.1 million in 2021, then soared by 1205.59% to $14.7 million in 2022, then fell by 24.97% to $11.1 million in 2023, then surged by 84.07% to $20.4 million in 2024, then tumbled by 61.83% to $7.8 million in 2025.
  • Its Cash & Current Investments was $7.8 million in Q3 2025, compared to $11.7 million in Q2 2025 and $9.1 million in Q1 2025.